Stephanie Long
Family Medicine · Warrensburg, MONPI 1477594927
Payments from drug & device makers
Across 105 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$450
- Novo Nordisk$240
- Organogenesis Inc.$133
- Pfizer$79
- Lilly USA, LLC$74
- Novartis$71
- plus $711 from 26 others
What the payments were for
- Food & beverage$1,759100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $450 |
| Novo Nordisk | 16 | $240 |
| Organogenesis Inc. | 5 | $133 |
| Pfizer | 6 | $79 |
| Lilly USA, LLC | 5 | $74 |
| Novartis | 4 | $71 |
| Amgen | 5 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Johnson & Johnson | 3 | $46 |
| Acadia Pharmaceuticals Inc | 2 | $43 |
| Smith+Nephew | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 3 | $40 |
| Astellas Pharma US Inc | 2 | $38 |
| Bayer | 2 | $36 |
| AstraZeneca | 2 | $26 |
| Merck | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Mylan Specialty L.p. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Dexcom, Inc. | 1 | $25 |
| Vertex | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Organon | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Melinta Therapeutics, LLC | 1 | $11 |
How this compares
$1,759 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 11 | $8,092 |
| Praluent PenAlirocumab | 12 | $6,100 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $4,997 |
| Humalog Kwikpen U-100Insulin Lispro | 16 | $2,550 |
| Omeprazole | 62 | $1,414 |
| Duloxetine Hcl | 50 | $1,413 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $1,188 |
| Omega-3 Acid Ethyl Esters | 12 | $1,136 |
| Tizanidine Hcl | 42 | $1,083 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $1,024 |
| Famotidine | 84 | $1,008 |
| Gabapentin | 58 | $981 |
| Rosuvastatin Calcium | 98 | $882 |
| Etodolac ErEtodolac | 12 | $863 |
| Pantoprazole Sodium | 95 | $840 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $74 | $8,09211 claims |
| AstraZenecaSymbicort | $26 | $4,99714 claims |
| AbbVieSynthroid | $450 | $57912 claims |
| Teva Pharmaceuticals USA, Inc.Acyclovir | $25 | $46313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Warrensburg
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.